Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
The summary for the Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional): The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) of the U.S. Department of Health and Human Services is seeking a Single Source renewal application to continue scientific service as the Scientific and Data Coordination Center for the Liver Cirrhosis Network.The application will be peer-reviewed and if it is not a meritorious application, it will not be funded. This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
| Federal Grant Title: | Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DK-26-309 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.847 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | January 27th, 2027 |
| Original Application Deadline: | January 27th, 2027 |
| Posted Date: | January 9th, 2026 |
| Creation Date: | January 9th, 2026 |
| Archive Date: | March 29th, 2027 |
| Total Program Funding: | $1,850,000 |
| Maximum Federal Grant Award: | $1,850,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 1 |
| Cost Sharing or Matching: | No |
| Last Updated: | January 9th, 2026 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to Section III. Eligibility Information within the NOFO for additional information on eligibility.Eligible OrganizationsOnly the following applicant is eligible to apply for this single source funding: Northwestern University. Please refer to Section I. Notice of Funding Opportunity Information for more details.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- Division of Digestive Diseases and Nutrition
[email protected]
[email protected] - Similar Government Grants
- • Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common M...
- • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...
- • Diabetes Research Centers (P30 Clinical Trial Optional)
- • Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical ...
- • Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinic...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research ...
- • Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
- • Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowe...
- • BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U...
- • Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common M...
